Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | FCGR1A | P12314 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 5/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | KCNJ6 | P48051 | 1/20 | 0.51 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.51 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13292368 | 0.86 | MAPK1 (0.58) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL28620570 | 0.86 | MAPK1 (0.47) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL11441588 | 0.86 | CYP1A2 (0.47) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL30490040 | 0.82 | MAPT (0.47) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL10712366 | 0.82 | CYP1A2 (0.53) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL23403503 | 0.82 | ALDH1A1 (0.67) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL11436903 | 0.82 | MAPK1 (0.44) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL10707004 | 0.82 | POLB (0.60) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 | |
| SCHEMBL12467265 | 0.82 | GAA (0.63) | CYP1A2CYP2C19NPC1RAB9ANTRK1 | |
| SCHEMBL10780565 | 0.82 | MAPK1 (0.61) | MAPK1CYP1A2CYP2C19FCGR1ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113336704-B | Danshensu derivative and preparation method and medical application thereof | 上海大学 | 2022-10-11 | — | — | CN | claimed |
| CN-113336704-A | Danshensu derivative and preparation method and medical application thereof | 上海大学 | 2021-09-03 | — | — | CN | claimed |
| US-4816454-A | CARDIOVASCULAR DISORDERS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1989-03-28 | — | — | US | claimed |
| EP-0175363-A2 | 4,5-Dihydro-3(2H)-pyridazinones, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1986-03-26 | — | — | EP | claimed |
| US-3945991-A | Heterocyclic azo compounds containing a quaternated hydrazide group | CIBA-GEIGY AG (CH) | 1976-03-23 | — | — | US | claimed |
| CN-122029152-A | Antioxidant drug conjugate FPR1 modulators, compositions comprising the modulators, and methods of use thereof | 百放开曼有限公司 | 2026-05-12 | — | — | CN | disclosed |
| WO-2025118148-A1 | ANTIOXIDANT DRUG-CONJUGATE MODULATORS OF FPR1, COMPOSITIONS COMPRISING THE MODULATOR, AND METHODS OF USING THE SAME | BIOFRONT LTD (KY) | 2025-06-12 | — | — | WO | disclosed |
| CN-119930520-A | N-aryl pyrazole compound, and pharmaceutical composition and application thereof | 中国药科大学 | 2025-05-06 | — | — | CN | disclosed |
| CN-113880805-B | 4-Substituted quinoline derivative, preparation method and application thereof | 东莞市东阳光农药研发有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119143824-A | 3-Methyl-1-phenyl-1H-pyrazole-5-O-beta-D-glucoside and preparation method, pharmaceutical composition and application thereof | 江苏万高药业股份有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-11912664-B2 | Determining small molecule-protein and protein-protein interactions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-02-27 | — | — | US | disclosed |
| CN-117069714-A | Bis (pyrazolyl) methane derivative and application thereof | 中国药科大学 | 2023-11-17 | — | — | CN | disclosed |
| EP-0185620-A2 | Monoazo compounds | CIBA-GEIGY AG (CH) | 1986-06-25 | — | — | EP | disclosed |
| EP-0177710-A1 | Phenyl urea derivatives | BAYER AG (DE) | 1986-04-16 | — | — | EP | disclosed |
| US-4517254-A | ALKALI METAL HYDROXIDE, AMINOALKYLPOLYACID COMPOUNT | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-05-14 | — | — | US | disclosed |
| EP-0139090-A1 | Process for the pre-treatment of polyimides | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-05-02 | — | — | EP | disclosed |
| US-4248632-A | ACTIVATION OF A POLYMER SURFACE WITH A PALLADIUM COMPLEX SALT | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-02-03 | — | — | US | disclosed |
| US-4217272-A | DYEING CELLULOSIC FIBERS | STERLING DRUG INC. (US) | 1980-08-12 | — | — | US | disclosed |
| US-4153598-A | Monoazo and diazo colorants from aminoalkylanilines and bis(aminoalkyl)anilines | STERLING DRUG INC. (US) | 1979-05-08 | — | — | US | disclosed |
| US-3945991-A | Heterocyclic azo compounds containing a quaternated hydrazide group | CIBA-GEIGY AG (CH) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912664-B2 | Determining small molecule-protein and protein-protein interactions | MAX, IK, CRYAA | MAPK1 1809/4885CYP1A2 4117/4885CYP2C19 4530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.